Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Aktiesnakken
  4. Aktiesnakken — Juni 2016

Aktiesnakken — Juni 2016

Planlagt Fastgjort Låst Flyttet Aktiesnakken
485 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • M Offline
    M Offline
    MUFC_Oberanven
    wrote on sidst redigeret af
    #209

    LinkedIn op 50% i premarket: Microsoft to acquire LinkedIn - PR Newswire
    13-Jun-2016 15:22:06
    For best results when printing this announcement, please click on link below: http://pdf.reuters.com/htmlnews/htmlnews.asp...

    Microsoft to acquire LinkedIn Deal brings together the world's leading professional cloud with the world's leading professional network. PR Newswire

    1 Reply Last reply
    0
    • P Offline
      P Offline
      pauly
      wrote on sidst redigeret af
      #210

      ærgeligt man ikke har dem

      1 Reply Last reply
      0
      • O Offline
        O Offline
        OHW
        wrote on sidst redigeret af
        #211

        Er der nogen steder man kan følge Novo's præsentation??

        1 Reply Last reply
        0
        • H Offline
          H Offline
          henrik48
          wrote on sidst redigeret af
          #212

          Der må vel snart være nyt om Novo fra New Orleans ??

          1 Reply Last reply
          0
          • CeletusC Offline
            CeletusC Offline
            Celetus
            wrote on sidst redigeret af
            #213

            CV death reduced by 22%

            1 Reply Last reply
            0
            • CeletusC Offline
              CeletusC Offline
              Celetus
              wrote on sidst redigeret af
              #214

              all cause death by 15% and 3 point MACE by 13%

              1 Reply Last reply
              0
              • M Offline
                M Offline
                MUFC_Oberanven
                wrote on sidst redigeret af
                #215

                Via twitter dukker fantatiske Novo nyheder op 🙂

                1 Reply Last reply
                0
                • M Offline
                  M Offline
                  MUFC_Oberanven
                  wrote on sidst redigeret af
                  #216

                  5% op i morgen på Novo

                  1 Reply Last reply
                  0
                  • CeletusC Offline
                    CeletusC Offline
                    Celetus
                    wrote on sidst redigeret af
                    #217

                    Enig.

                    1 Reply Last reply
                    0
                    • CeletusC Offline
                      CeletusC Offline
                      Celetus
                      wrote on sidst redigeret af
                      #218

                      imponerende produkt

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        MUFC_Oberanven
                        wrote on sidst redigeret af
                        #219

                        New Orleans, US, 13 June 2016 – Novo Nordisk today announced that Victoza® (liraglutide) significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke by 13% vs placebo (95% confidence interval [CI]: 0.78; 0.97, p=0.01), when added to standard of care in 9,340 adults with type 2 diabetes at high CV risk. The main results of the LEADER trial were presented today at the American Diabetes Association

                        1 Reply Last reply
                        0
                        • M Offline
                          M Offline
                          MUFC_Oberanven
                          wrote on sidst redigeret af
                          #220

                          There was a significant 22% reduction in cardiovascular death with Victoza® treatment vs placebo (95% CI: 0.66; 0.93, p=0.007) and reductions in non-fatal myocardial infarction (HR=0.88, 95% CI: 0.75; 1.03, p=0.11) and non-fatal stroke (HR=0.89, 95% CI: 0.72; 1.11, p=0.30).1, 2

                          1 Reply Last reply
                          0
                          • Den_FattigeD Offline
                            Den_FattigeD Offline
                            Den_Fattige
                            wrote on sidst redigeret af
                            #221

                            Er det godt eller skide godt ??

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #222

                              http://www.proinvestor.com/aktienyt/HUG2020216/Victoza®-viser-signifikant-reduktion-af-risikoen-for-alvorlige-kardiovaskulaere-haendelser-og-doed-hos-voksne-med-type-2-diabetes-i-LEADER-studiet

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                MUFC_Oberanven
                                wrote on sidst redigeret af
                                #223

                                Åbenbart så er disse Victoza Data nok som forventet.

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #224

                                  God morgen. 🙂

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #225

                                    En god gennem omkring data på Victosa. http://www.proinvestor.com/investornyt/377774/novo-victoza-vaekker-laeger-og-diabetikere-til-live

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #226

                                      gennemgang

                                      1 Reply Last reply
                                      0
                                      • LivermoreL Offline
                                        LivermoreL Offline
                                        Livermore
                                        wrote on sidst redigeret af
                                        #227

                                        I forhold til forventningerne fra Citigroup er data lidt skuffende: https://www.landbobanken.dk/investering/aktiefokus

                                        1 Reply Last reply
                                        0
                                        • TeamGarlicT Offline
                                          TeamGarlicT Offline
                                          TeamGarlic
                                          wrote on sidst redigeret af
                                          #228

                                          Godmorgen fellas

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper